Unapproved gene therapy for boosting longevity is set to go on sale | HappeningNow.news
Published Date: June 23, 2026

Science · 1 views

Unapproved gene therapy for boosting longevity is set to go on sale

A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at ove…

Source New Scientist AI Summary Updated 2h 48m ago
Story intelligence Beta
Freshness Fresh Updated 2h 48m ago
Confidence Limited Single-outlet story
Coverage Single outlet
Views 1 Community interest
Read time 1 min ~31 words

AI Summary

A gene therapy that instructs cells to produce more of an anti-ageing protein called klotho is about to be offered by a US company at overseas clinics to bypass FDA rules

Read full article on Newscientist

AI summaries can be wrong sometimes—always verify important details using the source article.

More coverage on this topic

FDA67 stories
View all FDA coverage
SUPPORT HAPPENINGNOW · Independent AI News Intelligence
SUPPORTER MESSAGE

Enjoyed this article? Consider supporting HappeningNow to help keep independent AI-powered news analysis moving forward. Your contribution helps cover infrastructure, AI summaries, and continued platform development.

Support HappeningNow